Mala Murthy - Apr 4, 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol: TDOC
Transactions as of: Apr 4, 2025
Transactions value $: -$51,012
Form type: 4
Date filed: 4/8/2025, 04:23 PM
Previous filing: Mar 21, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+12.7K	+10.88%		129K	Apr 4, 2025	Direct	F1
transaction	TDOC	Common Stock	Sale	-$51K	-7.49K	-5.81%	$6.81	121K	Apr 7, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-12.7K	-33.33%	$0.00	25.3K	Apr 4, 2025	Common Stock	12.7K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.